Quotient Sciences (Alnwick) Limited
Manufacture of basic pharmaceutical products · Nottingham
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2017-12-31
IXBRL · 288 source facts · 28 selected values
Not assessedlegacy record
Accounts to 2017-12-31
IXBRL · 288 source facts · 28 selected values
Not assessed
legacy record
- Reporting period
- 2017-01-01 to 2017-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 205
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0052_09767194_20171231
- Source archive
- Accounts_Monthly_Data-March2018.zip
Accounts to 2016-12-31
IXBRL · 175 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2016-12-31
IXBRL · 175 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2015-09-08 to 2016-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 96
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0042_09767194_20161231
- Source archive
- Accounts_Monthly_Data-May2017.zip
Registered details
09767194- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-09-08
- Jurisdiction
- —
- Registered office
- C/O QUOTIENT SCIENCES LIMITED TRENT HOUSE, MERE WAY, RUDDINGTON FIELDS BUSINESS PARK, NOTTINGHAM, NG11 6JS, ENGLAND
Classification
3 SIC codes211002120072110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsSUMMIT - SUstainable Manufacture of Macromolecular Intracellular TherapeuticsLiveInnovate UK · Collaborative R&D · 2025-02-01 – 2027-01-31 · with 4 other participants£204,978awarded
SUMMIT - SUstainable Manufacture of Macromolecular Intracellular TherapeuticsLive
Innovate UK · Collaborative R&D · 2025-02-01 – 2027-01-31 · with 4 other participants
£204,978
awarded
University of Nottingham£224,913
Quotient Sciences (Alnwick) Limited£204,978
ETERNAL - Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycleLead
Innovate UK · EU-Funded · 2022-09-01 – 2026-08-31
£455,394
awarded
ETERNAL - Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycleLeadActive
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-08-30
£455,394
whole project
ETERNAL - Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycleActive
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2026-08-30
£455,394
whole project
Fill-Inova: Enabling flexible and agile highly potent medicines manufacture
ISCF · Collaborative R&D · 2018-12-01 – 2019-03-31
£1,036,395
whole project
Fill-Inova: Enabling flexible and agile highly potent medicines manufactureLead
ISCF · Collaborative R&D · 2018-12-01 – 2019-03-31
£1,036,395
whole project
Fill-Inova: Enabling flexible and agile highly potent medicines manufactureLead
Innovate UK · Collaborative R&D · 2018-12-01 – 2019-03-31
£1,036,395
awarded